Dr. Dall'Era is on Doximity
As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office4860 Y Street
Sacramento, CA 95864Phone(916) 734-2893
- Is this information wrong?
Education & Training
- University of WashingtonResidency, Urology, 2000 - 2006
- University of WashingtonResidency, General Surgery, 2000 - 2002
- University of California Davis School of MedicineClass of 2000
Certifications & Licensure
- FL State Medical License 2021 - 2023
- CA State Medical License 2006 - 2022
- WA State Medical License 2000 - 2006
- American Board of Urology Urology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2012
- An Integrated Phase II/III, Open Label, Randomized and Controlled Study of the Safety and Efficacy of CG0070 Adenovirus Vector Expressing GM-CSF in Patients With Non-Muscle Invasive Bladder Cancer With Carcinoma In Situ Disease Who Have Failed BCG Start of enrollment: 2014 Mar 01DeRidder, P.,Meng, M.V.,Yeung, A.W.
- Niraparib Before Surgery in Treating Patients With High Risk Localized Prostate Cancer and DNA Damage Response Defects Marc Dall'Era
Publications & Presentations
- Association of age with response to preoperative chemotherapy in patients with muscle-invasive bladder cancer.David D'Andrea, Peter C. Black, Homayoun Zargar, Kamran Zargar-Shoshtari, Francesco Soria, Adrian Fairey, Laura S. Mertens, Colin P.N. Dinney, Maria Carmen Mir, Laura-...> ;World Journal of Urology. 2021 Aug 9
- 25-year perspective on prostate cancer: Conquering frontiers and understanding tumor biology.Tanya B. Dorff, Brock O'Neil, Karen E. Hoffman, Daniel W. Lin, Kevin R. Loughlin, Marc A. Dall'Era> ;Urologic Oncology-seminars and Original Investigations. 2021 Jul 12
- Phase Ib trial of reformulated niclosamide with abiraterone/prednisone in men with castration-resistant prostate cancer.Mamta Parikh, Chengfei Liu, Chun Yi Wu, Christopher P. Evans, Marc A. Dall'Era, Daniel Robles, Primo N. Lara, Neeraj Agarwal, Allen C. Gao, Chong-Xian Pan> ;Scientific Reports. 2021 Mar 18
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: